FREMONT, CA--(Marketwired - Aug 8, 2016) - Optovue, the global leader in the development and commercialization of optical coherence tomography angiography (OCTA), today announced a partnership with ROCOL SA, a medical equipment distributor in Colombia. ROCOL focuses on providing the highest quality products in the areas of ophthalmology, oncology, aesthetics and surgery.
"Optovue is extremely proud to be partnering with one of the premier leaders in the marketing and distribution of ophthalmology products in Colombia," said John Hawley, senior vice president, global sales for Optovue. "ROCOL has superb relationships with doctors, a strong understanding of patient care, and a successful track record of representing high-end, leading technologies in Latin America. We look forward to a long and productive relationship."
Optovue's newest product, the AngioVue™ Imaging System, with its groundbreaking, proprietary technology, provides clinicians with a non-invasive, dyeless technique for quickly visualizing the presence or absence of flow in the blood vessels in the retina and choroid. Optovue is the first company to develop and commercialize this pioneering OCTA technology worldwide. Since its introduction, over 100 peer-reviewed articles have featured AngioVue technology.
"Our partnership with Optovue is extremely important to advancing eye care in the Colombian market," said Juan David Toro, director of ophthalmic sales for ROCOL. "We are pleased to bring the leading edge technologies represented in Optovue's product portfolio to our doctors, as this enables ROCOL to deliver a full suite of ophthalmological products to the market."
With this new agreement, Optovue continues its reputation of partnering with leading distributors across the Americas to provide the significant benefits of non-invasive OCTA that aid in the detection and monitoring of sight-threatening diseases.
Optovue, Inc., a privately-held medical device company founded in 2003 and based in Fremont, Calif., is dedicated to the development and commercialization of high-speed optical coherence technology used to facilitate the diagnosis and management of eye diseases, many of which may lead to permanent blindness. For more information, visit www.optovue.com.
About ROCOL SA
ROCOL SA is engaged in the marketing and distribution of medical equipment across Latin America, Brazil and the Caribbean Islands. Since its' founding in 1984, the company has supported medical professionals by delivering technologies for ophthalmology, oncology, aesthetics and surgical needs. For more information, visit www.rocol.com.co.